英文名称 Anti-H1N1 Hemagglutinin 2

中文名称 甲型流感血凝素抗体

别 名 HA; HA2; Hemagglutinin; Influenza A Virus [A/California/04/2009(H1N1)].

浓 度 1mg/1ml

规 格 0.1ml/100μg 0.2ml/200μg

抗体来源 Rabbit

克隆类型 polyclonal

交叉反应 Influenza A virus H1N1

产品类型 一抗

研究领域 细菌及

蛋白分子量 predicted molecular weight: 63kDa

性 状 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from Influenza A Virus Hemagglutinin C-terminus

亚 型 IgG

纯化方法 affinity purified by Protein A

储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蜡切片需做抗原修复）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by the end user.

保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

产品介绍 Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species jumping ability.

Influenza A Virus [A/California/04/2009(H1N1)]

Database links : GenBank: ACQ76318.1

英文名称 Anti-H1N1 Hemagglutinin 2 中文名称 甲型流感血凝素抗体 别 名 HA; HA2; Hemagglutinin; Influenza A Virus [A/California/04/2009(H1N1)]. 浓 度 1mg/1ml 规 格 0.1ml/100μg 0.2ml/200μg 抗体来源 Rabbit 克隆类型 polyclonal 交叉反应 Influenza A virus H1N1 产品类型 一抗 研究领域 细菌及
蛋白分子量 predicted molecular weight: 63kDa 性 状 Lyophilized or Liquid 免 疫 原 KLH conjugated synthetic peptide derived from Influenza A Virus Hemagglutinin C-terminus 亚 型 IgG 纯化方法 affinity purified by Protein A 储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide 产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复）  not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. 保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 产品介绍 Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species jumping ability.Influenza A Virus [A/California/04/2009(H1N1)]Database links : GenBank: ACQ76318.1英文名称 Anti-H1N1 Hemagglutinin 2 英文名称 Anti-H1N1 Hemagglutinin 2 英文名称 Anti-H1N1 Hemagglutinin 2 英文名称 Anti-H1N1 Hemagglutinin 2 英文名称 Anti-H1N1 Hemagglutinin 2中文名称 甲型流感血凝素抗体 中文名称 甲型流感血凝素抗体 中文名称 甲型流感血凝素抗体 中文名称 甲型流感血凝素抗体 中文名称 甲型流感血凝素抗体别 名 HA; HA2; Hemagglutinin; Influenza A Virus [A/California/04/2009(H1N1)]. 别 名 HA; HA2; Hemagglutinin; Influenza A Virus [A/California/04/2009(H1N1)]. 别 名 HA; HA2; Hemagglutinin; Influenza A Virus [A/California/04/2009(H1N1)]. 别 名 HA; HA2; Hemagglutinin; Influenza A Virus [A/California/04/2009(H1N1)]. 别 名 HA; HA2; Hemagglutinin; Influenza A Virus [A/California/04/2009(H1N1)].浓 度 1mg/1ml 浓 度 1mg/1ml 浓 度 1mg/1ml 浓 度 1mg/1ml 浓 度 1mg/1ml规 格 0.1ml/100μg 0.2ml/200μg 规 格 0.1ml/100μg 0.2ml/200μg 规 格 0.1ml/100μg 0.2ml/200μg 规 格 0.1ml/100μg 0.2ml/200μg 规 格 0.1ml/100μg 0.2ml/200μg抗体来源 Rabbit 抗体来源 Rabbit 抗体来源 Rabbit 抗体来源 Rabbit 抗体来源 Rabbit克隆类型 polyclonal 克隆类型 polyclonal 克隆类型 polyclonal 克隆类型 polyclonal 克隆类型 polyclonal交叉反应 Influenza A virus H1N1 交叉反应 Influenza A virus H1N1 交叉反应 Influenza A virus H1N1 交叉反应 Influenza A virus H1N1 交叉反应 Influenza A virus H1N1产品类型 一抗 产品类型 一抗 产品类型 一抗 产品类型 一抗 产品类型 一抗研究领域 细菌及
研究领域 细菌及
研究领域 细菌及
研究领域 细菌及
研究领域 细菌及
蛋白分子量 predicted molecular weight: 63kDa 蛋白分子量 predicted molecular weight: 63kDa 蛋白分子量 predicted molecular weight: 63kDa 蛋白分子量 predicted molecular weight: 63kDa 蛋白分子量 predicted molecular weight: 63kDa性 状 Lyophilized or Liquid 性 状 Lyophilized or Liquid 性 状 Lyophilized or Liquid 性 状 Lyophilized or Liquid 性 状 Lyophilized or Liquid免 疫 原 KLH conjugated synthetic peptide derived from Influenza A Virus Hemagglutinin C-terminus 免 疫 原 KLH conjugated synthetic peptide derived from Influenza A Virus Hemagglutinin C-terminus 免 疫 原 KLH conjugated synthetic peptide derived from Influenza A Virus Hemagglutinin C-terminus 免 疫 原 KLH conjugated synthetic peptide derived from Influenza A Virus Hemagglutinin C-terminus 免 疫 原 KLH conjugated synthetic peptide derived from Influenza A Virus Hemagglutinin C-terminus亚 型 IgG 亚 型 IgG 亚 型 IgG 亚 型 IgG 亚 型 IgG纯化方法 affinity purified by Protein A 纯化方法 affinity purified by Protein A 纯化方法 affinity purified by Protein A 纯化方法 affinity purified by Protein A 纯化方法 affinity purified by Protein A储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide 储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide 储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide 储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide 储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500（石蜡切片需做抗原修复） （石蜡切片需做抗原修复） （石蜡切片需做抗原修复） （石蜡切片需做抗原修复） （石蜡切片需做抗原修复） not yet tested in other applications. not yet tested in other applications. not yet tested in other applications. not yet tested in other applications. not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.  optimal dilutions/concentrations should be determined by the end user.  optimal dilutions/concentrations should be determined by the end user.  optimal dilutions/concentrations should be determined by the end user.  optimal dilutions/concentrations should be determined by the end user.保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.产品介绍 Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species jumping ability.产品介绍 Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species jumping ability.产品介绍 Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species jumping ability.产品介绍 Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species jumping ability.产品介绍 Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species jumping ability.Influenza A Virus [A/California/04/2009(H1N1)]Influenza A Virus [A/California/04/2009(H1N1)]Influenza A Virus [A/California/04/2009(H1N1)]Influenza A Virus [A/California/04/2009(H1N1)]Influenza A Virus [A/California/04/2009(H1N1)]Database links : GenBank: ACQ76318.1Database links : GenBank: ACQ76318.1Database links : GenBank: ACQ76318.1Database links : GenBank: ACQ76318.1Database links : GenBank: ACQ76318.1

白头翁皂苷B4	Anemoside B4	129741-57-7	HPLC-ELS-D≥95%
白鲜碱	Dictamnine	484-29-7	HPLC≥98%
白杨素	Chrysin	480-40-0	HPLC≥98%
白芷属脑	Heraclenol	31575-93-6	HPLC≥98%
百秋李醇	Patchouli alcohol	5986-55-0	GC≥98%
百蕊草素I	Kaempferol-3-O-glucorhamnoside	40437-72-7	HPLC≥98%
百蕊草素I	Kaempferol-3-O-glucorhamnoside	40437-72-7	HPLC≥98%
半边旗4F	4F of perissemipinnatal		HPLC≥98%
半边旗5F	5F of perissemipinnatal		HPLC≥98%
半齿泽兰素	Bulk Inquiry	855-96-9	HPLC≥98%
胞苷	Cytidine	65-46-3	HPLC≥98%
胞嘧啶	Cytosine	71-30-7	HPLC≥98%
宝藿苷I	Baohuoside I	113558-15-9	HPLC≥98%
宝藿苷I	Baohuoside I	113558-15-9	HPLC≥98%
宝藿苷II	Baohuoside II	55395-07-8	HPLC≥98%
杯苋甾酮	Cyasterone	17086-76-9	HPLC≥98%
北美芹素	Pteryxin	13161-75-6	HPLC≥98%
贝萼皂苷元	Bayogenin	6989-24-8	HPLC≥98%

白头翁皂苷B4Anemoside B4129741-57-7HPLC-ELS-D≥95%白鲜碱Dictamnine484-29-7HPLC≥98%白杨素Chrysin480-40-0HPLC≥98%白芷属脑Heraclenol31575-93-6HPLC≥98%百秋李醇Patchouli alcohol5986-55-0GC≥98%百蕊草素IKaempferol-3-O-glucorhamnoside40437-72-7HPLC≥98%百蕊草素IKaempferol-3-O-glucorhamnoside40437-72-7HPLC≥98%半边旗4F4F of perissemipinnatalHPLC≥98%半边旗5F5F of perissemipinnatalHPLC≥98%半齿泽兰素Bulk Inquiry855-96-9HPLC≥98%胞苷Cytidine65-46-3HPLC≥98%胞嘧啶Cytosine71-30-7HPLC≥98%宝藿苷IBaohuoside I113558-15-9HPLC≥98%宝藿苷IBaohuoside I113558-15-9HPLC≥98%宝藿苷IIBaohuoside II55395-07-8HPLC≥98%杯苋甾酮Cyasterone17086-76-9HPLC≥98%北美芹素Pteryxin13161-75-6HPLC≥98%贝萼皂苷元Bayogenin6989-24-8HPLC≥98%白头翁皂苷B4Anemoside B4129741-57-7HPLC-ELS-D≥95%白头翁皂苷B4白头翁皂苷B4白头翁皂苷B4白头翁皂苷B4Anemoside B4Anemoside B4Anemoside B4Anemoside B4129741-57-7129741-57-7129741-57-7129741-57-7HPLC-ELS-D≥95%HPLC-ELS-D≥95%HPLC-ELS-D≥95%HPLC-ELS-D≥95%白鲜碱Dictamnine484-29-7HPLC≥98%白鲜碱白鲜碱白鲜碱白鲜碱DictamnineDictamnineDictamnineDictamnine484-29-7484-29-7484-29-7484-29-7HPLC≥98%HPLC≥98%HPLC≥98%HPLC≥98%白杨素Chrysin480-40-0HPLC≥98%白杨素白杨素白杨素白杨素ChrysinChrysinChrysinChrysin480-40-0480-40-0480-40-0480-40-0HPLC≥98%HPLC≥98%HPLC≥98%HPLC≥98%白芷属脑Heraclenol31575-93-6HPLC≥98%白芷属脑白芷属脑白芷属脑白芷属脑HeraclenolHeraclenolHeraclenolHeraclenol31575-93-631575-93-631575-93-631575-93-6HPLC≥98%HPLC≥98%HPLC≥98%HPLC≥98%百秋李醇Patchouli alcohol5986-55-0GC≥98%百秋李醇百秋李醇百秋李醇百秋李醇Patchouli alcoholPatchouli alcoholPatchouli alcoholPatchouli alcohol5986-55-05986-55-05986-55-05986-55-0GC≥98%GC≥98%GC≥98%GC≥98%百蕊草素IKaempferol-3-O-glucorhamnoside40437-72-7HPLC≥98%百蕊草素I百蕊草素I百蕊草素I百蕊草素IKaempferol-3-O-glucorhamnosideKaempferol-3-O-glucorhamnosideKaempferol-3-O-glucorhamnosideKaempferol-3-O-glucorhamnoside40437-72-740437-72-740437-72-740437-72-7HPLC≥98%HPLC≥98%HPLC≥98%HPLC≥98%百蕊草素IKaempferol-3-O-glucorhamnoside40437-72-7HPLC≥98%百蕊草素I百蕊草素I百蕊草素I百蕊草素IKaempferol-3-O-glucorhamnosideKaempferol-3-O-glucorhamnosideKaempferol-3-O-glucorhamnosideKaempferol-3-O-glucorhamnoside40437-72-740437-72-740437-72-740437-72-7HPLC≥98%HPLC≥98%HPLC≥98%HPLC≥98%半边旗4F4F of perissemipinnatalHPLC≥98%半边旗4F半边旗4F半边旗4F半边旗4F4F of perissemipinnatal4F of perissemipinnatal4F of perissemipinnatal4F of perissemipinnatalHPLC≥98%HPLC≥98%HPLC≥98%HPLC≥98%半边旗5F5F of perissemipinnatalHPLC≥98%半边旗5F半边旗5F半边旗5F半边旗5F5F of perissemipinnatal5F of perissemipinnatal5F of perissemipinnatal5F of perissemipinnatalHPLC≥98%HPLC≥98%HPLC≥98%HPLC≥98%半齿泽兰素Bulk Inquiry855-96-9HPLC≥98%半齿泽兰素半齿泽兰素半齿泽兰素半齿泽兰素Bulk InquiryBulk InquiryBulk InquiryBulk Inquiry855-96-9855-96-9855-96-9855-96-9HPLC≥98%HPLC≥98%HPLC≥98%HPLC≥98%胞苷Cytidine65-46-3HPLC≥98%胞苷胞苷胞苷胞苷CytidineCytidineCytidineCytidine65-46-365-46-365-46-365-46-3HPLC≥98%HPLC≥98%HPLC≥98%HPLC≥98%胞嘧啶Cytosine71-30-7HPLC≥98%胞嘧啶胞嘧啶胞嘧啶胞嘧啶CytosineCytosineCytosineCytosine71-30-771-30-771-30-771-30-7HPLC≥98%HPLC≥98%HPLC≥98%HPLC≥98%宝藿苷IBaohuoside I113558-15-9HPLC≥98%宝藿苷I宝藿苷I宝藿苷I宝藿苷IBaohuoside IBaohuoside IBaohuoside IBaohuoside I113558-15-9113558-15-9113558-15-9113558-15-9HPLC≥98%HPLC≥98%HPLC≥98%HPLC≥98%宝藿苷IBaohuoside I113558-15-9HPLC≥98%宝藿苷I宝藿苷I宝藿苷I宝藿苷IBaohuoside IBaohuoside IBaohuoside IBaohuoside I113558-15-9113558-15-9113558-15-9113558-15-9HPLC≥98%HPLC≥98%HPLC≥98%HPLC≥98%宝藿苷IIBaohuoside II55395-07-8HPLC≥98%宝藿苷II宝藿苷II宝藿苷II宝藿苷IIBaohuoside IIBaohuoside IIBaohuoside IIBaohuoside II55395-07-855395-07-855395-07-855395-07-8HPLC≥98%HPLC≥98%HPLC≥98%HPLC≥98%杯苋甾酮Cyasterone17086-76-9HPLC≥98%杯苋甾酮杯苋甾酮杯苋甾酮杯苋甾酮CyasteroneCyasteroneCyasteroneCyasterone17086-76-917086-76-917086-76-917086-76-9HPLC≥98%HPLC≥98%HPLC≥98%HPLC≥98%北美芹素Pteryxin13161-75-6HPLC≥98%北美芹素北美芹素北美芹素北美芹素PteryxinPteryxinPteryxinPteryxin13161-75-613161-75-613161-75-613161-75-6HPLC≥98%HPLC≥98%HPLC≥98%HPLC≥98%贝萼皂苷元Bayogenin6989-24-8HPLC≥98%贝萼皂苷元贝萼皂苷元贝萼皂苷元贝萼皂苷元BayogeninBayogeninBayogeninBayogenin6989-24-86989-24-86989-24-86989-24-8HPLC≥98%HPLC≥98%HPLC≥98%HPLC≥98%